Delivery Order SPE2DB22D2006-SPE2DB24FV6CZ
Award Date 11/12/23
Potential Completion Date 11/13/23
Potential Value $9.2K
Federal Agency
Ultimate Awardee
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This federal contract award was issued by the Defense Logistics Agency (DLA) to the prime contractor, Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The $39,439.89 Firm Fixed Price Delivery Order contract is for the supply of ACTIVASE 100 MG VIALS, a pharmaceutical product, to support military healthcare programs. The contract has a period of performance through February 9, 2024 and was awarded on February 8, 2024. Amerisourcebergen Drug Corp holds a significant $999,999,999...
- This federal contract award, with a ceiling value of $24,939.56, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of ACTIVASE 100 MG VIALS, a specialized pharmaceutical product. The award is a Delivery Order under an existing Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00 and running through November 2026....
- This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distribution company, for the supply of ACTIVASE 100 MG VIALS. The contract is a Delivery Order with a Firm Fixed Price of $17,141.55 and has an Ultimate Completion Date of June 4, 2024. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at up to $999,999,999.00 through December 31, 2025. This single-award...
- This federal contract award, with ID SPE2DB20D1109|SPE2DB24FP58V, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $21,694.13 firm fixed-price delivery order is for the supply of 4565264443 ACTIVASE 100 MG VIALS. The contract has an ultimate completion date of July 29, 2024. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
- This federal contract award, valued at $15,753.67, was granted to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, a delivery order under Indefinite Delivery Contract SPE2DB20D1109, was awarded by the Defense Logistics Agency (DLA) to provide 4555456824 ACTIVASE 100 MG VIALS. The award has a firm fixed price and an ultimate completion date of November 18, 2021. Amerisourcebergen Drug Corp is a subsidiary of the parent company...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $17,141.52 Firm Fixed Price delivery order is for the supply of ACTIVASE 100 MG VIALS, a critical medical product. The contract has an ultimate completion date of October 25, 2024 and was awarded on October 24, 2024. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $12,546.32 firm fixed-price delivery order is for the supply of 4566240526 ACTIVASE 100 MG vials, with a period of performance through October 29, 2024. The contract is not designated with a set-aside requirement, indicating open competition. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery...
- This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is for the delivery of medical supplies, specifically 4563045503 - ACTIVASE 100 MG VIALS. The award, valued at $14,508.97, is a Delivery Order under a larger Indefinite Delivery Contract (IDC) with the Defense Logistics Agency (DLA) Troop Support Medical, worth up to $999,999,999.00 and running through November 2026. This IDC serves as the primary vehicle for Amerisourcebergen to provide a comprehensive...
- The federal contract award is for the delivery of ACTIVASE 50 MG VIALS to the Defense Logistics Agency (DLA), a defense agency. The contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, with a ceiling value of $8,316.16. The contract is a delivery order with firm fixed pricing and has an ultimate completion date of July 17, 2025. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA...
- This federal contract award, with ID SPE2DB20D3103|SPE2DB22FM5Y4, is a delivery order valued at $22,384.79 issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of ACTIVASE 100 MG VIALS, a critical medical product, to support military healthcare programs. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which holds a significant $999,999,999 Indefinite Delivery Contract (IDC)...